Akari Therapeutics plc (AKTX)
Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer
Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer
Citius Oncology - Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
Gilead - Gilead Foundation Awards Over $3 Million to Support People Living With Metastatic Breast Cancer
Alcon - Alcon Announces Amended Merger Agreement with STAAR Surgical
HCA Healthcare - HCA Healthcare Names Virginia Tenpenny Vice President of Community Engagement
Clene to Present at the Emerging Growth Conference
Clene to Present at the Emerging Growth Conference
Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition
Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection